Purpose The US National Cancer Institute (NCI) Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) was developed to enable patient reporting of symptomatic adverse events in oncology clinical research. This study was designed to assess the feasibility and resource requirements associated with implementing PRO-CTCAE in a multicenter trial. Methods Patients with locally advanced rectal cancer enrolled in the National Cancer Institute-sponsored North Central Cancer Treatment Group (Alliance) Preoperative Radiation or Selective Preoperative Radiation and Evaluation before Chemotherapy and Total Mesorectal Excision trial were asked to self-report 30 PRO-CTCAE items weekly from home during preoperat...
Objective: The study sought to describe patient-entered supplemental information on symptomatic adve...
Background: The aim was to examine the feasibility, acceptability and clinical utility of electronic...
Background: The Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Eve...
Purpose The US National Cancer Institute (NCI) Patient-Reported Outcomes version of the Common Termi...
The National Cancer Institute (NCI) is developing a patient-reported version of its Common Terminolo...
Purpose—To assess the feasibility of measuring symptomatic adverse events (AEs) in a multicenter cli...
Symptomatic adverse events (AEs) in cancer trials are currently reported by clinicians using the Nat...
The National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria...
Systematic capture of the patient perspective can inform the development of new cancer therapies. Pa...
IMPORTANCE: In cancer clinical trials, symptomatic adverse events (AEs), such as nausea, are reporte...
IMPORTANCE Standard adverse event (AE) reporting in oncology clinical trials has historically relied...
Symptomatic adverse events (AEs) are monitored by clinicians as part of all US-based clinical trials...
ImportanceIn cancer clinical trials, symptomatic adverse events (AEs), such as nausea, are reported ...
Background: The Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Eve...
Aims—The U.S. National Cancer Institute recently developed the Patient-Reported Outcomes version of ...
Objective: The study sought to describe patient-entered supplemental information on symptomatic adve...
Background: The aim was to examine the feasibility, acceptability and clinical utility of electronic...
Background: The Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Eve...
Purpose The US National Cancer Institute (NCI) Patient-Reported Outcomes version of the Common Termi...
The National Cancer Institute (NCI) is developing a patient-reported version of its Common Terminolo...
Purpose—To assess the feasibility of measuring symptomatic adverse events (AEs) in a multicenter cli...
Symptomatic adverse events (AEs) in cancer trials are currently reported by clinicians using the Nat...
The National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria...
Systematic capture of the patient perspective can inform the development of new cancer therapies. Pa...
IMPORTANCE: In cancer clinical trials, symptomatic adverse events (AEs), such as nausea, are reporte...
IMPORTANCE Standard adverse event (AE) reporting in oncology clinical trials has historically relied...
Symptomatic adverse events (AEs) are monitored by clinicians as part of all US-based clinical trials...
ImportanceIn cancer clinical trials, symptomatic adverse events (AEs), such as nausea, are reported ...
Background: The Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Eve...
Aims—The U.S. National Cancer Institute recently developed the Patient-Reported Outcomes version of ...
Objective: The study sought to describe patient-entered supplemental information on symptomatic adve...
Background: The aim was to examine the feasibility, acceptability and clinical utility of electronic...
Background: The Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Eve...